About iSTAR Medical
iSTAR Medical is a Healthcare company based in Wavre (Belgium) founded in 2010. Minimally invasive glaucoma surgery implants are developed for open-angle treatment. iSTAR Medical has raised $60.84 million across 4 funding rounds from investors including BNP Paribas Fortis, Gimv and Life Sciences Partners. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy.
Company details
iSTAR Medical was founded in 2010 in Wavre, Belgium, within the medical device sector focused on ophthalmology. Operations center on the development of minimally invasive glaucoma surgery (MIGS) implants. The flagship product, MINIject, is designed for patients with open-angle glaucoma and is constructed from a proprietary silicone material known as STAR. Natural fluid outflow is enhanced by this material, which also reduces intraocular pressure.
- Headquarters Wavre, Belgium
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website istar-medical.com
- Social LinkedIn X YouTube
- Total Equity Funding$60.84M (USD)
in 4 rounds
- Latest Funding Round$44.03M (USD), Series C
Sep 2019
- InvestorsBNP Paribas Fortis
& 13 more
Apps and channels of iSTAR Medical
its YouTube channel iSTAR Medical has 121 subscribers and 30 videos.
Videos from iSTAR Medical
The most watched videos on iSTAR Medical's YouTube channel, iSTAR Medical (121 subscribers). Click a video to play it here.
More on iSTAR Medical.
Funding Insights of iSTAR Medical
iSTAR Medical has successfully raised a total of $60.84M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $44.03 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60.84M
- Total Rounds 4
- Last Round Series C — $44.03M
- First Round $4.65M
(Sep 2012)
- Investors Count 14
All 4 funding rounds of iSTAR Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $44.03M | Series C | – | Life Sciences Partners, Gimv | |
| Apr 2016 | $11.41M | Series B | – | Capricorn Partners, SRIW | – |
| Nov 2013 | $5.41M | Series A | – | SRIW, Namur Invest | |
| Sep 2012 | $4.65M | Grant | – | – |
14 investors in total: 13 institutional and 1 angel.
Investors in iSTAR Medical
iSTAR Medical has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas Fortis, Gimv and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
Private equity firm | 1980 | gimv.com | Antwerp, Belgium | |
Earlybird is recognized as a venture capital investor focused on early-stage tech companies. | earlybird.com | Berlin, Germany | ||
Investments are directed by Capricorn Partners into European tech ventures. | 1993 | capricorn.be | Leuven, Belgium | |
Buyouts are pursued by SRIW as a private equity firm. | sriw.be | Liege, Belgium | ||
Private equity is directed toward private and public companies. | sfpi-fpim.be | Brussels, Belgium | ||
Demeter is recognized as a major European investor in venture capital and private equity for energy and ecological transition. | demeter-im.com | Paris, France | ||
Investment and financing services are provided for entrepreneurs in Walloon Brabant. | investbw.be | Louvain-la-Neuve, Belgium | ||
Investsud is engaged in investment and support for SMEs. | capitaletcroissance.be | Marche-en-Famenne, Belgium | ||
Retail banking services are offered across multiple sectors. | 1934 | bnpparibasfortis.com | Brussels, Belgium |
Investor details for iSTAR Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of iSTAR Medical
3 dated milestones of iSTAR Medical across 9 years, from founding to its latest funding, stage changes and deals.
- Founded iSTAR Medical is founded.
- Funding First funding round of $4.7M.
- Funding Latest funding round, Series C, of $44.0M.
Web traffic of iSTAR Medical
The website of iSTAR Medical (istar-medical.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 170.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Istar Medical
Complete news archive for iSTAR Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iSTAR Medical
iSTAR Medical was founded in 2010 and raised its 1st funding round 2 years after it was founded.
iSTAR Medical is headquartered in Wavre, Belgium. It is registered at Wavre, Walloon Brabant, Belgium.
iSTAR Medical is a funded company, having raised a total of $60.84M across 4 funding rounds to date. The company's 1st funding round was a Grant of $4.65M, raised on Sep 2012.
iSTAR Medical was founded in 2010 in Wavre, Belgium, within the medical device sector focused on ophthalmology. Operations center on the development of minimally invasive glaucoma surgery (MIGS) implants. The flagship product, MINIject, is designed for patients with open-angle glaucoma and is constructed from a proprietary silicone material known as STAR. Natural fluid outflow is enhanced by this material, which also reduces intraocular pressure.
iSTAR Medical has 14 investors. Key investors include BNP Paribas Fortis, Gimv, Life Sciences Partners, Capricorn Partners, and Wallonia.